Phytochemicals and their impact on adipose tissue inflammation and diabetes

Vascular Pharmacology

Volumn 58, Issue 1-2, 2013, Pages 3-20

  Leiherer, Andreas ^a,c,d   Mündlein, Axel ^a,c   Drexel, Heinz ^a,b,c,e  

^a Vorarlberg Institute for Vascular Investigation and Treatment VIVIT   (Austria)

^b Academic Teaching Hospital Feldkirch   (Austria)

^c PRIVATE UNIVERSITY OF THE PRINCIPALITY OF LIECHTENSTEIN   (Liechtenstein)

^d Medical Central Laboratory   (Austria)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Adipocytes; Diabetes; Inflammation; Resveratrol; Western diet

Indexed keywords

ADIPONECTIN; CAPSAICIN; CATECHIN; CURCUMIN; GENISTEIN; GINGEROL; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE 1; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT MEDICINAL PRODUCT; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADIPOSE TISSUE; CACAO; DIABETES MELLITUS; ENERGY CONSUMPTION; ENERGY EXPENDITURE; ENERGY RESOURCE; HUMAN; HYPOXIA; INFLAMMATION; METABOLIC REGULATION; MITOCHONDRION; NONHUMAN; NUTRITION; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; THERMOGENESIS; UBIQUITINATION; WEIGHT GAIN;

ADIPOSE TISSUE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL AGENTS; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 84871717518     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.09.002     Document Type: Review

References (378)

1. Abbey E.L., Rankin J.W. Effect of quercetin supplementation on repeated-sprint performance, xanthine oxidase activity, and inflammation. Int. J. Sport Nutr. Exerc. Metab. 2011, 21:91-96.
2. Abd El-Aziz T.A., Mohamed R.H., Pasha H.F., Abdel-Aziz H.R. Catechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated rats. Clin. Exp. Med. 2011, 10.1007/s10238-011-0165-2.
3. Agarwal A., Prasad R., Jain A. Effect of green tea extract (catechins) in reducing oxidative stress seen in patients of pulmonary tuberculosis on DOTS Cat I regimen. Phytomedicine 2010, 17:23-27.
4. Ahn J., Lee H., Kim S., Ha T. Resveratrol inhibits TNF-alpha-induced changes of adipokines in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2007, 364:972-977.
5. Ahn J., Lee H., Kim S., Park J., Ha T. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem. Biophys. Res. Commun. 2008, 373:545-549.
6. Ahn J., Lee H., Kim S., Ha T. Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/beta-catenin signaling. Am. J. Physiol. Cell Physiol. 2010, 298:C1510-C1516.
7. Ahuja K.D., Ball M.J. Effects of daily ingestion of chilli on serum lipoprotein oxidation in adult men and women. Br. J. Nutr. 2006, 96:239-242.
8. Ahuja K.D., Robertson I.K., Geraghty D.P., Ball M.J. Effects of chili consumption on postprandial glucose, insulin, and energy metabolism. Am. J. Clin. Nutr. 2006, 84:63-69.
9. Ahuja K.D., Robertson I.K., Geraghty D.P., Ball M.J. The effect of 4-week chilli supplementation on metabolic and arterial function in humans. Eur. J. Clin. Nutr. 2007, 61:326-333.
10. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 1987, 262:5592-5595.
11. Al Amin Z.M., Thomson M., Al Qattan K.K., Peltonen-Shalaby R., Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br. J. Nutr. 2006, 96:660-666.
12. Alcain F.J., Villalba J.M. Sirtuin activators. Expert Opin. Ther. Pat. 2009, 19:403-414.
13. Alizadeh-Navaei R., Roozbeh F., Saravi M., Pouramir M., Jalali F., Moghadamnia A.A. Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial. Saudi Med. J. 2008, 29:1280-1284.
14. Alwi I., Santoso T., Suyono S., Sutrisna B., Suyatna F.D., Kresno S.B., Ernie S. The effect of curcumin on lipid level in patients with acute coronary syndrome. Acta Med. Indones. 2008, 40:201-210.
15. Appendino G., Belcaro G., Cornelli U., Luzzi R., Togni S., Dugall M., Cesarone M.R., Feragalli B., Ippolito E., Errichi B.M., Pellegrini L., Ledda A., Ricci A., Bavera P., Hosoi M., Stuard S., Corsi M., Errichi S., Gizzi G. Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. Panminerva Med. 2011, 53:43-49.
16. Asai A., Miyazawa T. Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J. Nutr. 2001, 131:2932-2935.
17. Backesjo C.M., Li Y., Lindgren U., Haldosen L.A. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J. Bone Miner. Res. 2006, 21:993-1002.
18. Bae M.K., Kim S.H., Jeong J.W., Lee Y.M., Kim H.S., Kim S.R., Yun I., Bae S.K., Kim K.W. Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1. Oncol. Rep. 2006, 15:1557-1562.
19. Bae S.C., Jung W.J., Lee E.J., Yu R., Sung M.K. Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. J. Am. Coll. Nutr. 2009, 28:56-62.
20. Baer D.J., Novotny J.A., Harris G.K., Stote K., Clevidence B., Rumpler W.V. Oolong tea does not improve glucose metabolism in non-diabetic adults. Eur. J. Clin. Nutr. 2011, 65:87-93.
21. Bai L., Pang W.J., Yang Y.J., Yang G.S. Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol. Cell. Biochem. 2008, 307:129-140.
22. Baluchnejadmojarad T., Roghani M. Chronic administration of genistein improves aortic reactivity of streptozotocin-diabetic rats: mode of action. Vascul. Pharmacol. 2008, 49:1-5.
23. Basu A., Sanchez K., Leyva M.J., Wu M., Betts N.M., Aston C.E., Lyons T.J. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J. Am. Coll. Nutr. 2010, 29:31-40.
24. Basu A., Du M., Sanchez K., Leyva M.J., Betts N.M., Blevins S., Wu M., Aston C.E., Lyons T.J. Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 2011, 27:206-213.
25. Baum L., Cheung S.K., Mok V.C., Lam L.C., Leung V.P., Hui E., Ng C.C., Chow M., Ho P.C., Lam S., Woo J., Chiu H.F., Goggins W., Zee B., Wong A., Mok H., Cheng W.K., Fong C., Lee J.S., Chan M.H., Szeto S.S., Lui V.W., Tsoh J., Kwok T.C., Chan I.H., Lam C.W. Curcumin effects on blood lipid profile in a 6-month human study. Pharmacol. Res. 2007, 56:509-514.
26. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo R., Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
27. Beattie J.H., Nicol F., Gordon M.J., Reid M.D., Cantlay L., Horgan G.W., Kwun I.S., Ahn J.Y., Ha T.Y. Ginger phytochemicals mitigate the obesogenic effects of a high-fat diet in mice: a proteomic and biomarker network analysis. Mol. Nutr. Food Res. 2011, 55(Suppl. 2):S203-S213.
28. Beher D., Wu J., Cumine S., Kim K.W., Lu S.C., Atangan L., Wang M. Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem. Biol. Drug Des. 2009, 74:619-624.
29. Belcaro G., Cesarone M.R., Dugall M., Pellegrini L., Ledda A., Grossi M.G., Togni S., Appendino G. Efficacy and safety of Meriva(R), a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern. Med. Rev. 2010, 15:337-344.
30. Bès-Houtmann S., Roche R., Hoareau L., Gonthier M.P., Festy F., Caillens H., Gasque P., Lefebvre d.C., Cesari M. Presence of functional TLR2 and TLR4 on human adipocytes. Histochem. Cell Biol. 2007, 127:131-137.
31. Bigelman K.A., Fan E.H., Chapman D.P., Freese E.C., Trilk J.L., Cureton K.J. Effects of six weeks of quercetin supplementation on physical performance in ROTC cadets. Mil. Med. 2010, 175:791-798.
32. Boots A.W., Drent M., de Boer V.C., Bast A., Haenen G.R. Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis. Clin. Nutr. 2011, 30:506-512.
33. Borra M.T., Smith B.C., Denu J.M. Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem. 2005, 280:17187-17195.
34. Boschmann M., Thielecke F. The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study. J. Am. Coll. Nutr. 2007, 26:389S-395S.
35. Boström P., Wu J., Jedrychowski M.P., Korde A., Ye L., Lo J.C., Rasbach K.A., Bostrom E.A., Choi J.H., Long J.Z., Kajimura S., Zingaretti M.C., Vind B.F., Tu H., Cinti S., Hojlund K., Gygi S.P., Spiegelman B.M. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481:463-468.
36. Brasnyo P., Molnar G.A., Mohas M., Marko L., Laczy B., Cseh J., Mikolas E., Szijarto I.A., Merei A., Halmai R., Meszaros L.G., Sumegi B., Wittmann I. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr. 2011, 106:383-389.
37. Brossette T., Hundsdorfer C., Kroncke K.D., Sies H., Stahl W. Direct evidence that (-)-epicatechin increases nitric oxide levels in human endothelial cells. Eur. J. Nutr. 2011, 50:595-599.
38. Brown A.L., Lane J., Coverly J., Stocks J., Jackson S., Stephen A., Bluck L., Coward A., Hendrickx H. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br. J. Nutr. 2009, 101:886-894.
39. Brown V.A., Patel K.R., Viskaduraki M., Crowell J.A., Perloff M., Booth T.D., Vasilinin G., Sen A., Schinas A.M., Piccirilli G., Brown K., Steward W.P., Gescher A.J., Brenner D.E. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 2010, 70:9003-9011.
40. Brown A.L., Lane J., Holyoak C., Nicol B., Mayes A.E., Dadd T. Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. Br. J. Nutr. 2011, 106:1880-1889.
41. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
42. Burke B., Giannoudis A., Corke K.P., Gill D., Wells M., Ziegler-Heitbrock L., Lewis C.E. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am. J. Pathol. 2003, 163:1233-1243.
43. Burnett B.P., Pillai L., Bitto A., Squadrito F., Levy R.M. Evaluation of CYP450 inhibitory effects and steady-state pharmacokinetics of genistein in combination with cholecalciferol and citrated zinc bisglycinate in postmenopausal women. Int. J. Womens Health 2011, 3:139-150.
44. Busby M.G., Jeffcoat A.R., Bloedon L.T., Koch M.A., Black T., Dix K.J., Heizer W.D., Thomas B.F., Hill J.M., Crowell J.A., Zeisel S.H. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am. J. Clin. Nutr. 2002, 75:126-136.
45. Calder P.C. Polyunsaturated fatty acids and inflammation. Biochem. Soc. Trans. 2005, 33:423-427.
46. Cao Z., Fang J., Xia C., Shi X., Jiang B.H. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin. Cancer Res. 2004, 10:5253-5263.
47. Capurso C., Capurso A. From excess adiposity to insulin resistance: the role of free fatty acids. Vascul. Pharmacol. 2012, 57:91-97.
48. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824.
49. Chacon M.R., Ceperuelo-Mallafre V., Maymo-Masip E., Mateo-Sanz J.M., Arola L., Guitierrez C., Fernandez-Real J.M., Ardevol A., Simon I., Vendrell J. Grape-seed procyanidins modulate inflammation on human differentiated adipocytes in vitro. Cytokine 2009, 47:137-142.
50. Chaiyasit K., Khovidhunkit W., Wittayalertpanya S. Pharmacokinetic and the effect of capsaicin in Capsicum frutescens on decreasing plasma glucose level. J. Med. Assoc. Thai. 2009, 92:108-113.
51. Chan M.M., Mattiacci J.A., Hwang H.S., Shah A., Fong D. Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem. Pharmacol. 2000, 60:1539-1548.
52. Charles C., Yuskavage J., Carlson O., John M., Tagalicud A.S., Maggio M., Muller D.C., Egan J., Basaria S. Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause 2009, 16:395-400.
53. Chen S.C., Liu Y.C., Shyu K.G., Wang D.L. Acute hypoxia to endothelial cells induces activating transcription factor 3 (ATF3) expression that is mediated via nitric oxide. Atherosclerosis 2008, 201:281-288.
54. Chen C.J., Yu W., Fu Y.C., Wang X., Li J.L., Wang W. Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway. Biochem. Biophys. Res. Commun. 2009, 378:389-393.
55. Chen N., Bezzina R., Hinch E., Lewandowski P.A., Cameron-Smith D., Mathai M.L., Jois M., Sinclair A.J., Begg D.P., Wark J.D., Weisinger H.S., Weisinger R.S. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutr. Res. 2009, 29:784-793.
56. Chen S., Li Z., Li W., Shan Z., Zhu W. Resveratrol inhibits cell differentiation in 3T3-L1 adipocytes via activation of AMPK. Can. J. Physiol. Pharmacol. 2011, 89:793-799.
57. Cheng Z., White M.F. Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. Antioxid. Redox Signal. 2011, 14:649-661.
58. Cho J.W., Lee K.S., Kim C.W. Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int. J. Mol. Med. 2007, 19:469-474.
59. Cho H.Y., Park C.M., Kim M.J., Chinzorig R., Cho C.W., Song Y.S. Comparative effect of genistein and daidzein on the expression of MCP-1, eNOS, and cell adhesion molecules in TNF-alpha-stimulated HUVECs. Nutr. Res. Pract. 2011, 5:381-388.
60. Choi H., Chun Y.S., Kim S.W., Kim M.S., Park J.W. Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. Mol. Pharmacol. 2006, 70:1664-1671.
61. Choi S.Y., Kim S., Son D., Lee P., Lee J., Lee S., Kim D.S., Park Y., Kim S.Y. Protective effect of (4-methoxybenzylidene)-(3-methoxynophenyl)amine against neuronal cell death induced by oxygen and glucose deprivation in rat organotypic hippocampal slice culture. Biol. Pharm. Bull. 2007, 30:189-192.
62. Choi S.E., Kim T.H., Yi S.A., Hwang Y.C., Hwang W.S., Choe S.J., Han S.J., Kim H.J., Kim D.J., Kang Y., Lee K.W. Capsaicin attenuates palmitate-induced expression of macrophage inflammatory protein 1 and interleukin 8 by increasing palmitate oxidation and reducing c-Jun activation in THP-1 (human acute monocytic leukemia cell) cells. Nutr. Res. 2011, 31:468-478.
63. Chuang C.C., Martinez K., Xie G., Kennedy A., Bumrungpert A., Overman A., Jia W., McIntosh M.K. Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. Am. J. Clin. Nutr. 2010, 92:1511-1521.
64. Chung J.Y., Park J.O., Phyu H., Dong Z., Yang C.S. Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3'-digallate. FASEB J. 2001, 15:2022-2024.
65. Corder R., Mullen W., Khan N.Q., Marks S.C., Wood E.G., Carrier M.J., Crozier A. Oenology: red wine procyanidins and vascular health. Nature 2006, 444:566.
66. Costa C.S., Rohden F., Hammes T.O., Margis R., Bortolotto J.W., Padoin A.V., Mottin C.C., Guaragna R.M. Resveratrol upregulated SIRT1, FOXO1, and adiponectin and downregulated PPARgamma1-3 mRNA expression in human visceral adipocytes. Obes. Surg. 2011, 21:356-361.
67. Cummins E.P., Taylor C.T. Hypoxia-responsive transcription factors. Pflugers Arch. 2005, 450:363-371.
68. Cureton K.J., Tomporowski P.D., Singhal A., Pasley J.D., Bigelman K.A., Lambourne K., Trilk J.L., McCully K.K., Arnaud M.J., Zhao Q. Dietary quercetin supplementation is not ergogenic in untrained men. J. Appl. Physiol. 2009, 107:1095-1104.
69. Dal Pan A., Blanc S., Aujard F. Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity. BMC Physiol. 2010, 10:11.
70. Danesi F., Di Nunzio M., Boschetti E., Bordoni A. Green tea extract selectively activates peroxisome proliferator-activated receptor beta/delta in cultured cardiomyocytes. Br. J. Nutr. 2009, 101:1736-1739.
71. Dang Z.C., Audinot V., Papapoulos S.E., Boutin J.A., Lowik C.W. Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J. Biol. Chem. 2003, 278:962-967.
72. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
73. Davis J.M., Murphy E.A., Carmichael M.D., Davis B. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R1071-R1077.
74. Davis J.M., Carlstedt C.J., Chen S., Carmichael M.D., Murphy E.A. The dietary flavonoid quercetin increases VO(2max) and endurance capacity. Int. J. Sport Nutr. Exerc. Metab. 2010, 20:56-62.
75. de Boer V.C., de Goffau M.C., Arts I.C., Hollman P.C., Keijer J. SIRT1 stimulation by polyphenols is affected by their stability and metabolism. Mech. Ageing Dev. 2006, 127:618-627.
76. de Kleijn M.J., van der Schouw Y.T., Wilson P.W., Adlercreutz H., Mazur W., Grobbee D.E., Jacques P.F. Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study(1-4). J. Nutr. 2001, 131:1826-1832.
77. Dedov V.N., Tran V.H., Duke C.C., Connor M., Christie M.J., Mandadi S., Roufogalis B.D. Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br. J. Pharmacol. 2002, 137:793-798.
78. Derdemezis C.S., Kiortsis D.N., Tsimihodimos V., Petraki M.P., Vezyraki P., Elisaf M.S., Tselepis A.D. Effect of plant polyphenols on adipokine secretion from human SGBS adipocytes. Biochem. Res. Int. 2011, 2011:285618.
79. Dhillon N., Aggarwal B.B., Newman R.A., Wolff R.A., Kunnumakkara A.B., Abbruzzese J.L., Ng C.S., Badmaev V., Kurzrock R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 2008, 14:4491-4499.
80. Diepvens K., Westerterp K.R., Westerterp-Plantenga M.S. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R77-R85.
81. Domingo D.S., Camouse M.M., Hsia A.H., Matsui M., Maes D., Ward N.L., Cooper K.D., Baron E.D. Anti-angiogenic effects of epigallocatechin-3-gallate in human skin. Int. J. Clin. Exp. Pathol. 2010, 3:705-709.
82. Dömötör A., Szolcsányi J., Mózsik G. Capsaicin and glucose absorption and utilization in healthy human subjects. Eur. J. Pharmacol. 2006, 534:280-283.
83. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 2011, 11:98-107.
84. Dong S.Z., Zhao S.P., Wu Z.H., Yang J., Xie X.Z., Yu B.L., Nie S. Curcumin promotes cholesterol efflux from adipocytes related to PPARgamma-LXRalpha-ABCA1 passway. Mol. Cell. Biochem. 2011, 358:281-285.
85. Dormandy J.A., Charbonnel B., Eckland D.J., Erdmann E., Massi-Benedetti M., Moules I.K., Skene A.M., Tan M.H., Lefebvre P.J., Murray G.D., Standl E., Wilcox R.G., Wilhelmsen L., Betteridge J., Birkeland K., Golay A., Heine R.J., Koranyi L., Laakso M., Mokan M., Norkus A., Pirags V., Podar T., Scheen A., Scherbaum W., Schernthaner G., Schmitz O., Skrha J., Smith U., Taton J. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 2005, 366:1279-1289.
86. Du G., Lin H., Wang M., Zhang S., Wu X., Lu L., Ji L., Yu L. Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1alpha in tumor and normal cells. Cancer Chemother. Pharmacol. 2010, 65:277-287.
87. Dulloo A.G., Seydoux J., Girardier L., Chantre P., Vandermander J. Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int. J. Obes. Relat. Metab. Disord. 2000, 24:252-258.
88. Duvoix A., Blasius R., Delhalle S., Schnekenburger M., Morceau F., Henry E., Dicato M., Diederich M. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005, 223:181-190.
89. Dyerberg J., Schmidt E.B. n-3 fatty acids and cardiovascular disease-observations generated by studies in Greenland Eskimos. Wien. Klin. Wochenschr. 1989, 101:277-282.
90. Eaton S.B., Konner M. Paleolithic nutrition. A consideration of its nature and current implications. N. Engl. J. Med. 1985, 312:283-289.
91. Ebbesson S.O., Risica P.M., Ebbesson L.O., Kennish J.M., Tejero M.E. Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project. Int. J. Circumpolar Health 2005, 64:396-408.
92. Ebbesson S.O., Tejero M.E., Lopez-Alvarenga J.C., Harris W.S., Ebbesson L.O., Devereux R.B., MacCluer J.W., Wenger C., Laston S., Fabsitz R.R., Howard B.V., Comuzzie A.G. Individual saturated fatty acids are associated with different components of insulin resistance and glucose metabolism: the GOCADAN study. Int. J. Circumpolar Health 2010, 69:344-351.
93. Egert S., Wolffram S., Bosy-Westphal A., Boesch-Saadatmandi C., Wagner A.E., Frank J., Rimbach G., Mueller M.J. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J. Nutr. 2008, 138:1615-1621.
94. Egert S., Bosy-Westphal A., Seiberl J., Kurbitz C., Settler U., Plachta-Danielzik S., Wagner A.E., Frank J., Schrezenmeir J., Rimbach G., Wolffram S., Muller M.J. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br. J. Nutr. 2009, 102:1065-1074.
95. Egert S., Boesch-Saadatmandi C., Wolffram S., Rimbach G., Muller M.J. Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J. Nutr. 2010, 140:278-284.
96. Egert S., Rimbach G., Muller M.J. No evidence for a thermic effect of the dietary flavonol quercetin: a pilot study in healthy normal-weight women. Eur. J. Appl. Physiol. 2011, 111:869-873.
97. Ejaz A., Wu D., Kwan P., Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J. Nutr. 2009, 139:919-925.
98. Eldershaw T.P., Colquhoun E.Q., Dora K.A., Peng Z.C., Clark M.G. Pungent principles of ginger (Zingiber officinale) are thermogenic in the perfused rat hindlimb. Int. J. Obes. Relat. Metab. Disord. 1992, 16:755-763.
99. Erickson J.T., Millhorn D.E. Hypoxia and electrical stimulation of the carotid sinus nerve induce Fos-like immunoreactivity within catecholaminergic and serotoninergic neurons of the rat brainstem. J. Comp. Neurol. 1994, 348:161-182.
100. Famulla S., Horrighs A., Cramer A., Sell H., Eckel J. Hypoxia reduces the response of human adipocytes towards TNFalpha resulting in reduced NF-kappaB signaling and MCP-1 secretion. Int. J. Obes. 2011, 36:986-992. (Lond).
101. Fandrey J., Gorr T.A., Gassmann M. Regulating cellular oxygen sensing by hydroxylation. Cardiovasc. Res. 2006, 71:642-651.
102. Fischer-Posovszky P., Kukulus V., Tews D., Unterkircher T., Debatin K.M., Fulda S., Wabitsch M. Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner. Am. J. Clin. Nutr. 2010, 92:5-15.
103. Fleischmann E., Kurz A., Niedermayr M., Schebesta K., Kimberger O., Sessler D.I., Kabon B., Prager G. Tissue oxygenation in obese and non-obese patients during laparoscopy. Obes. Surg. 2005, 15:813-819.
104. Floyd Z.E., Wang Z.Q., Kilroy G., Cefalu W.T. Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol. Metabolism 2008, 57:S32-S38.
105. Fotsis T., Pepper M., Adlercreutz H., Hase T., Montesano R., Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J. Nutr. 1995, 125:790S-797S.
106. Fukino Y., Ikeda A., Maruyama K., Aoki N., Okubo T., Iso H. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur. J. Clin. Nutr. 2008, 62:953-960.
107. Geiger K., Leiherer A., Muendlein A., Stark N., Geller-Rhomberg S., Saely C.H., Wabitsch M., Fraunberger P., Drexel H. Identification of hypoxia-induced genes in human SGBS adipocytes by microarray analysis. PLoS One 2011, 6:e26465.
108. Geiger K., Muendlein A., Stark N., Saely C.H., Wabitsch M., Fraunberger P., Drexel H. Hypoxia induces apelin expression in human adipocytes. Horm. Metab. Res. 2011, 43:380-385.
109. Ghanim H., Sia C.L., Abuaysheh S., Korzeniewski K., Patnaik P., Marumganti A., Chaudhuri A., Dandona P. An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J. Clin. Endocrinol. Metab. 2010, 95:E1-E8.
110. Gonzalez-Muniesa P., de Oliveira C., Perez d.H., Thompson M.P., Trayhurn P. Fatty acids and hypoxia stimulate the expression and secretion of the adipokine ANGPTL4 (angiopoietin-like protein 4/fasting-induced adipose factor) by human adipocytes. J. Nutrigenet. Nutrigenomics 2011, 4:146-153.
111. Gresele P., Pignatelli P., Guglielmini G., Carnevale R., Mezzasoma A.M., Ghiselli A., Momi S., Violi F. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J. Nutr. 2008, 138:1602-1608.
112. Guarente L. Sirtuins as potential targets for metabolic syndrome. Nature 2006, 444:868-874.
113. Guevara-Aguirre J., Balasubramanian P., Guevara-Aguirre M., Wei M., Madia F., Cheng C.W., Hwang D., Martin-Montalvo A., Saavedra J., Ingles S., de Cabo R., Cohen P., Longo V.D. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 2011, 3:70ra13.
114. Gugler R., Leschik M., Dengler H.J. Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin. Pharmacol. 1975, 9:229-234.
115. Halberg N., Khan T., Trujillo M.E., Wernstedt-Asterholm I., Attie A.D., Sherwani S., Wang Z.V., Landskroner-Eiger S., Dineen S., Magalang U.J., Brekken R.A., Scherer P.E. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol. Cell. Biol. 2009, 29:4467-4483.
116. Hara Y., Fujino M., Adachi K., Li X.K. The reduction of hypoxia-induced and reoxygenation-induced apoptosis in rat islets by epigallocatechin gallate. Transplant. Proc. 2006, 38:2722-2725.
117. Hardie D.G. Sensing of energy and nutrients by AMP-activated protein kinase. Am. J. Clin. Nutr. 2011, 93:891S-896S.
118. Harmon A.W., Harp J.B. Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am. J. Physiol. Cell Physiol. 2001, 280:C807-C813.
119. Haxhiu M.A., Strohl K.P., Cherniack N.S. The N-methyl-d-aspartate receptor pathway is involved in hypoxia-induced c-Fos protein expression in the rat nucleus of the solitary tract. J. Auton. Nerv. Syst. 1995, 55:65-68.
120. He Z.Y., Shi C.B., Wen H., Li F.L., Wang B.L., Wang J. Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Invest. 2011, 29:208-213.
121. Heinz S.A., Henson D.A., Nieman D.C., Austin M.D., Jin F. A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects. Br. J. Nutr. 2010, 104:849-857.
122. Hill A.M., Coates A.M., Buckley J.D., Ross R., Thielecke F., Howe P.R. Can EGCG reduce abdominal fat in obese subjects?. J. Am. Coll. Nutr. 2007, 26:396S-402S.
123. Hirota K., Morikawa K., Hanada H., Nonaka M., Nakajima Y., Kobayashi M., Nakajima R. Effect of genistein and daidzein on the proliferation and differentiation of human preadipocyte cell line. J. Agric. Food Chem. 2010, 58:5821-5827.
124. Hollenberg K. Vascular action of cocoa flavanols in humans: the roots of the story. J. Cardiovasc. Pharmacol. 2006, 47(Suppl. 2):S99-S102.
125. Holmes-McNary M., Baldwin A.S. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res. 2000, 60:3477-3483.
126. Hong M.H., Kim M.H., Chang H.J., Kim N.H., Shin B.A., Ahn B.W., Jung Y.D. (-)-Epigallocatechin-3-gallate inhibits monocyte chemotactic protein-1 expression in endothelial cells via blocking NF-kappaB signaling. Life Sci. 2007, 80:1957-1965.
127. Horn-Ross P.L., John E.M., Lee M., Stewart S.L., Koo J., Sakoda L.C., Shiau A.C., Goldstein J., Davis P., Perez-Stable E.J. Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am. J. Epidemiol. 2001, 154:434-441.
128. Hosogai N., Fukuhara A., Oshima K., Miyata Y., Tanaka S., Segawa K., Furukawa S., Tochino Y., Komuro R., Matsuda M., Shimomura I. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007, 56:901-911.
129. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
130. Hsu C.L., Yen G.C. Induction of cell apoptosis in 3T3-L1 pre-adipocytes by flavonoids is associated with their antioxidant activity. Mol. Nutr. Food Res. 2006, 50:1072-1079.
131. Hsu C.L., Yen G.C. Effects of capsaicin on induction of apoptosis and inhibition of adipogenesis in 3T3-L1 cells. J. Agric. Food Chem. 2007, 55:1730-1736.
132. Hsu C.H., Liao Y.L., Lin S.C., Tsai T.H., Huang C.J., Chou P. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern. Med. Rev. 2011, 16:157-163.
133. Hwang J.T., Park I.J., Shin J.I., Lee Y.K., Lee S.K., Baik H.W., Ha J., Park O.J. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem. Biophys. Res. Commun. 2005, 338:694-699.
134. Hwang J.T., Kim S., Choi S.Y. Inhibitory effect of (E)-1,2-di(3,5-dimethoxyphenyl)ethene on 3T3-L1 adiopocyte differentiation. Pharmazie 2010, 65:903-905.
135. Ikonomov O.C., Sbrissa D., Mlak K., Shisheva A. Requirement for PIKfyve enzymatic activity in acute and long-term insulin cellular effects. Endocrinology 2002, 143:4742-4754.
136. Inami S., Takano M., Yamamoto M., Murakami D., Tajika K., Yodogawa K., Yokoyama S., Ohno N., Ohba T., Sano J., Ibuki C., Seino Y., Mizuno K. Tea catechin consumption reduces circulating oxidized low-density lipoprotein. Int. Heart J. 2007, 48:725-732.
137. Isa Y., Miyakawa Y., Yanagisawa M., Goto T., Kang M.S., Kawada T., Morimitsu Y., Kubota K., Tsuda T. 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-alpha mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2008, 373:429-434.
138. Islam M.S., Choi H. Comparative effects of dietary ginger (Zingiber officinale) and garlic (Allium sativum) investigated in a type 2 diabetes model of rats. J. Med. Food 2008, 11:152-159.
139. Ito T., Warnken S.P., May W.S. Protein synthesis inhibition by flavonoids: roles of eukaryotic initiation factor 2alpha kinases. Biochem. Biophys. Res. Commun. 1999, 265:589-594.
140. Jacob A., Wu R., Zhou M., Wang P. Mechanism of the anti-inflammatory effect of curcumin: PPAR-gamma activation. PPAR Res. 2007, 89369.
141. Jang E.M., Choi M.S., Jung U.J., Kim M.J., Kim H.J., Jeon S.M., Shin S.K., Seong C.N., Lee M.K. Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters. Metabolism 2008, 57:1576-1583.
142. Jiang H., Xie Z., Koo H.J., McLaughlin S.P., Timmermann B.N., Gang D.R. Metabolic profiling and phylogenetic analysis of medicinal Zingiber species: tools for authentication of ginger (Zingiber officinale Rosc). Phytochemistry 2006, 67:1673-1685.
143. Jin F., Nieman D.C., Shanely R.A., Knab A.M., Austin M.D., Sha W. The variable plasma quercetin response to 12-week quercetin supplementation in humans. Eur. J. Clin. Nutr. 2010, 64:692-697.
144. Jing Y., Han G., Hu Y., Bi Y., Li L., Zhu D. Tea consumption and risk of type 2 diabetes: a meta-analysis of cohort studies. J. Gen. Intern. Med. 2009, 24:557-562.
145. Jorgensen M.E., Borch-Johnsen K., Bjerregaard P. Lifestyle modifies obesity-associated risk of cardiovascular disease in a genetically homogeneous population. Am. J. Clin. Nutr. 2006, 84:29-36.
146. Jutooru I., Chadalapaka G., Lei P., Safe S. Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation. J. Biol. Chem. 2010, 285:25332-25344.
147. Kabon B., Nagele A., Reddy D., Eagon C., Fleshman J.W., Sessler D.I., Kurz A. Obesity decreases perioperative tissue oxygenation. Anesthesiology 2004, 100:274-280.
148. Kaeberlein M., McDonagh T., Heltweg B., Hixon J., Westman E.A., Caldwell S.D., Napper A., Curtis R., DiStefano P.S., Fields S., Bedalov A., Kennedy B.K. Substrate-specific activation of sirtuins by resveratrol. J. Biol. Chem. 2005, 280:17038-17045.
149. Kalpravidh R.W., Siritanaratkul N., Insain P., Charoensakdi R., Panichkul N., Hatairaktham S., Srichairatanakool S., Phisalaphong C., Rachmilewitz E., Fucharoen S. Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids. Clin. Biochem. 2010, 43:424-429.
150. Kanai M., Yoshimura K., Asada M., Imaizumi A., Suzuki C., Matsumoto S., Nishimura T., Mori Y., Masui T., Kawaguchi Y., Yanagihara K., Yazumi S., Chiba T., Guha S., Aggarwal B.B. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother. Pharmacol. 2011, 68:157-164.
151. Kanai M., Imaizumi A., Otsuka Y., Sasaki H., Hashiguchi M., Tsujiko K., Matsumoto S., Ishiguro H., Chiba T. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother. Pharmacol. 2012, 69:65-70.
152. Kang J.H., Kim C.S., Han I.S., Kawada T., Yu R. Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Lett. 2007, 581:4389-4396.
153. Kang J.H., Tsuyoshi G., Le Ngoc H., Kim H.M., Tu T.H., Noh H.J., Kim C.S., Choe S.Y., Kawada T., Yoo H., Yu R. Dietary capsaicin attenuates metabolic dysregulation in genetically obese diabetic mice. J. Med. Food 2011, 14:310-315.
154. Kawada T., Hagihara K., Iwai K. Effects of capsaicin on lipid metabolism in rats fed a high fat diet. J. Nutr. 1986, 116:1272-1278.
155. Kawada T., Watanabe T., Takaishi T., Tanaka T., Iwai K. Capsaicin-induced beta-adrenergic action on energy metabolism in rats: influence of capsaicin on oxygen consumption, the respiratory quotient, and substrate utilization. Proc. Soc. Exp. Biol. Med. 1986, 183:250-256.
156. Kawai T., Akira S. TLR signaling. Semin. Immunol. 2007, 19:24-32.
157. Kean B.H. The blood presure of the Cuna Indians. Am. J. Trop. Med. Hyg. 1944, 24:341-343.
158. Kennedy A., Overman A., Lapoint K., Hopkins R., West T., Chuang C.C., Martinez K., Bell D., McIntosh M. Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol. J. Lipid Res. 2009, 50:225-232.
159. Khajehdehi P., Pakfetrat M., Javidnia K., Azad F., Malekmakan L., Nasab M.H., Dehghanzadeh G. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-beta and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. Scand. J. Urol. Nephrol. 2011, 45:365-370.
160. Khokhar S., Magnusdottir S.G. Total phenol, catechin, and caffeine contents of teas commonly consumed in the United kingdom. J. Agric. Food Chem. 2002, 50:565-570.
161. Kim H., Sakamoto K. (-)-Epigallocatechin gallate suppresses adipocyte differentiation through the MEK/ERK and PI3K/AKT pathways. Cell Biol. Int. 2011, 36:147-153.
162. Kim C.S., Kawada T., Kim B.S., Han I.S., Choe S.Y., Kurata T., Yu R. Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages. Cell. Signal. 2003, 15:299-306.
163. Kim Y.A., Choi B.T., Lee Y.T., Park D.I., Rhee S.H., Park K.Y., Choi Y.H. Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells. Oncol. Rep. 2004, 11:441-446.
164. Kim S.O., Kundu J.K., Shin Y.K., Park J.H., Cho M.H., Kim T.Y., Surh Y.J. [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin. Oncogene 2005, 24:2558-2567.
165. Kim M.H., Kang K.S., Lee Y.S. The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease. Br. J. Nutr. 2010, 104:1333-1342.
166. Kim C.Y., Bordenave N., Ferruzzi M.G., Safavy A., Kim K.H. Modification of curcumin with polyethylene glycol enhances the delivery of curcumin in preadipocytes and its antiadipogenic property. J. Agric. Food Chem. 2011, 59:1012-1019.
167. Kim C.Y., Le T.T., Chen C., Cheng J.X., Kim K.H. Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion. J. Nutr. Biochem. 2011, 22:910-920.
168. Kim J.H., Park S.H., Nam S.W., Kwon H.J., Kim B.W., Kim W.J., Choi Y.H. Curcumin stimulates proliferation, stemness acting signals and migration of 3T3-L1 preadipocytes. Int. J. Mol. Med. 2011, 28:429-435.
169. Kim O.Y., Lee S.M., Do H., Moon J., Lee K.H., Cha Y.J., Shin M.J. Influence of quercetin-rich onion peel extracts on adipokine expression in the visceral adipose tissue of rats. Phytother. Res. 2011, 26:432-437.
170. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., Fischer-Posovszky P., Barth T.F., Dragun D., Skurk T., Hauner H., Bluher M., Unger T., Wolf A.M., Knippschild U., Hombach V., Marx N. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1304-1310.
171. Kipp J.L., Ramirez V.D. Effect of estradiol, diethylstilbestrol, and resveratrol on F0F1-ATPase activity from mitochondrial preparations of rat heart, liver, and brain. Endocrine 2001, 15:165-175.
172. Klimova T., Chandel N.S. Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ. 2008, 15:660-666.
173. Knab A.M., Shanely R.A., Henson D.A., Jin F., Heinz S.A., Austin M.D., Nieman D.C. Influence of quercetin supplementation on disease risk factors in community-dwelling adults. J. Am. Diet. Assoc. 2011, 111:542-549.
174. Kobori M., Masumoto S., Akimoto Y., Oike H. Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Mol. Nutr. Food Res. 2011, 55:530-540.
175. Konrad M., Nieman D.C., Henson D.A., Kennerly K.M., Jin F., Wallner-Liebmann S.J. The acute effect of ingesting a quercetin-based supplement on exercise-induced inflammation and immune changes in runners. Int. J. Sport Nutr. Exerc. Metab. 2011, 21:338-346.
176. Ku Y., Choi S. The scientific technology of kimchi. The Composition of Foods 1990, 33-34. Korean Institute of Food Development, Seoul, Korea.
177. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 2001, 81:807-869.
178. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
179. Lazarevic B., Boezelijn G., Diep L.M., Kvernrod K., Ogren O., Ramberg H., Moen A., Wessel N., Berg R.E., Egge-Jacobsen W., Hammarstrom C., Svindland A., Kucuk O., Saatcioglu F., Tasken K.A., Karlsen S.J. Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial. Nutr. Cancer 2011, 63:889-898.
180. Lee M.S., Kim Y. (-)-Epigallocatechin-3-gallate enhances uncoupling protein 2 gene expression in 3T3-L1 adipocytes. Biosci. Biotechnol. Biochem. 2009, 73:434-436.
181. Lee D.H., Lee Y.J. Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis. J. Cell. Biochem. 2008, 105:546-553.
182. Lee J.Y., Plakidas A., Lee W.H., Heikkinen A., Chanmugam P., Bray G., Hwang D.H. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J. Lipid Res. 2003, 44:479-486.
183. Lee Y.H., Giraud J., Davis R.J., White M.F. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem. 2003, 278:2896-2902.
184. Lee Y.M., Choi J.S., Kim M.H., Jung M.H., Lee Y.S., Song J. Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets. Nutrition 2006, 22:956-964.
185. Lee H., Lee Y.J., Choi H., Ko E.H., Kim J.W. Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. J. Biol. Chem. 2009, 284:10601-10609.
186. Lee Y.K., Lee W.S., Hwang J.T., Kwon D.Y., Surh Y.J., Park O.J. Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells. J. Agric. Food Chem. 2009, 57:305-310.
187. Lee M.S., Kim C.T., Kim I.H., Kim Y. Effects of capsaicin on lipid catabolism in 3T3-L1 adipocytes. Phytother. Res. 2011, 25:935-939.
188. Leiro J., Alvarez E., Garcia D., Orallo F. Resveratrol modulates rat macrophage functions. Int. Immunopharmacol. 2002, 2:767-774.
189. Leiro J., Alvarez E., Arranz J.A., Laguna R., Uriarte E., Orallo F. Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes. J. Leukoc. Biol. 2004, 75:1156-1165.
190. Lejeune M.P., Kovacs E.M., Westerterp-Plantenga M.S. Effect of capsaicin on substrate oxidation and weight maintenance after modest body-weight loss in human subjects. Br. J. Nutr. 2003, 90:651-659.
191. Leone M., Zhai D., Sareth S., Kitada S., Reed J.C., Pellecchia M. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res. 2003, 63:8118-8121.
192. Lewis J.D., Ferrara A., Peng T., Hedderson M., Bilker W.B., Quesenberry C.P., Vaughn D.J., Nessel L., Selby J., Strom B.L. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care 2011, 34:916-922.
193. Li Z., Ya K., Xiao-Mei W., Lei Y., Yang L., Ming Q.Z. Ginkgolides protect PC12 cells against hypoxia-induced injury by p42/p44 MAPK pathway-dependent upregulation of HIF-1alpha expression and HIF-1DNA-binding activity. J. Cell. Biochem. 2008, 103:564-575.
194. Li Y., Zhang J.F., Zhang Y.M., Ma X.B. The protective effect of genistein postconditioning on hypoxia/reoxygenation-induced injury in human gastric epithelial cells. Acta Pharmacol. Sin. 2009, 30:576-581.
195. Lichtenstein L., Mattijssen F., de Wit N.J., Georgiadi A., Hooiveld G.J., van der M.R., He Y., Qi L., Koster A., Tamsma J.T., Tan N.S., Muller M., Kersten S. Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell Metab. 2010, 12:580-592.
196. Lin Y.L., Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol. Pharmacol. 1997, 52:465-472.
197. Lin S.K., Shun C.T., Kok S.H., Wang C.C., Hsiao T.Y., Liu C.M. Hypoxia-stimulated vascular endothelial growth factor production in human nasal polyp fibroblasts: effect of epigallocatechin-3-gallate on hypoxia-inducible factor-1 alpha synthesis. Arch. Otolaryngol. Head Neck Surg. 2008, 134:522-527.
198. Linford N.J., Yang Y., Cook D.G., Dorsa D.M. Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and p42/44 mitogen-activated protein kinase. J. Pharmacol. Exp. Ther. 2001, 299:67-75.
199. Liu J., Divoux A., Sun J., Zhang J., Clement K., Glickman J.N., Sukhova G.K., Wolters P.J., Du J., Gorgun C.Z., Doria A., Libby P., Blumberg R.S., Kahn B.B., Hotamisligil G.S., Shi G.P. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 2009, 15:940-945.
200. Llaneza P., Gonzalez C., Fernandez-Inarrea J., Alonso A., Diaz F., Arnott I., Ferrer-Barriendos J. Soy isoflavones, diet and physical exercise modify serum cytokines in healthy obese postmenopausal women. Phytomedicine 2011, 18:245-250.
201. Lonac M.C., Richards J.C., Schweder M.M., Johnson T.K., Bell C. Influence of short-term consumption of the caffeine-free, epigallocatechin-3-gallate supplement, Teavigo, on resting metabolism and the thermic effect of feeding. Obesity (Silver Spring) 2011, 19:298-304.
202. Lu J., Guan S., Shen X., Qian W., Huang G., Deng X., Xie G. Immunosuppressive activity of 8-gingerol on immune responses in mice. Molecules 2011, 16:2636-2645.
203. Lubet R.A., Fischer S.M., Steele V.E., Juliana M.M., Desmond R., Grubbs C.J. Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers. Int. J. Cancer 2008, 123:2254-2259.
204. Ludy M.J., Mattes R.D. The effects of hedonically acceptable red pepper doses on thermogenesis and appetite. Physiol. Behav. 2011, 102:251-258.
205. Macarulla M.T., Alberdi G., Gomez S., Tueros I., Bald C., Rodriguez V.M., Martinez J.A., Portillo M.P. Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet. J. Physiol. Biochem. 2009, 65:369-376.
206. Mackenzie T., Leary L., Brooks W.B. The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study. Metabolism 2007, 56:1340-1344.
207. Mackenzie T., Zens M.S., Ferrara A., Schned A., Karagas M.R. Diabetes and risk of bladder cancer: evidence from a case-control study in New England. Cancer 2011, 117:1552-1556.
208. Mader I., Wabitsch M., Debatin K.M., Fischer-Posovszky P., Fulda S. Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis. FASEB J. 2010, 24:1997-2009.
209. Marini H., Bitto A., Altavilla D., Burnett B.P., Polito F., Di S.V., Minutoli L., Atteritano M., Levy R.M., Frisina N., Mazzaferro S., Frisina A., D'Anna R., Cancellieri F., Cannata M.L., Corrado F., Lubrano C., Marini R., Adamo E.B., Squadrito F. Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: a follow-up study. Nutr. Metab. Cardiovasc. Dis. 2010, 20:332-340.
210. Mark L., Nikfardjam M.S., Avar P., Ohmacht R. A validated HPLC method for the quantitative analysis of trans-resveratrol and trans-piceid in Hungarian wines. J. Chromatogr. Sci. 2005, 43:445-449.
211. Markovits J., Linassier C., Fosse P., Couprie J., Pierre J., Jacquemin-Sablon A., Saucier J.M., Le Pecq J.B., Larsen A.K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 1989, 49:5111-5117.
212. Martinez J., Moreno J.J. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol. 2000, 59:865-870.
213. Matsuyama T., Tanaka Y., Kamimaki I., Nagao T., Tokimitsu I. Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity (Silver Spring) 2008, 16:1338-1348.
214. Matthews C.P., Colburn N.H., Young M.R. AP-1 a target for cancer prevention. Curr. Cancer Drug Targets 2007, 7:317-324.
215. McCabe M.J., Orrenius S. Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase-II. Biochem. Biophys. Res. Commun. 1993, 194:944-950.
216. Melnik B.C., John S.M., Schmitz G. Over-stimulation of insulin/IGF-1 signaling by western diet may promote diseases of civilization: lessons learnt from laron syndrome. Nutr. Metab. (Lond.) 2011, 8:41.
217. Messina M., Nagata C., Wu A.H. Estimated Asian adult soy protein and isoflavone intakes. Nutr. Cancer 2006, 55:1-12.
218. Metzner J.E., Frank T., Kunz I., Burger D., Riegger C. Study on the pharmacokinetics of synthetic genistein after multiple oral intake in post-menopausal women. Arzneimittelforschung 2009, 59:513-520.
219. Middleton E., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52:673-751.
220. Miller R.J., Jackson K.G., Dadd T., Nicol B., Dick J.L., Mayes A.E., Brown A.L., Minihane A.M. A preliminary investigation of the impact of catechol-O-methyltransferase genotype on the absorption and metabolism of green tea catechins. Eur. J. Nutr. 2012, 51:47-55.
221. Miranda S., Gonzalez-Rodriguez A., Revuelta-Cervantes J., Rondinone C.M., Valverde A.M. Beneficial effects of PTP1B deficiency on brown adipocyte differentiation and protection against apoptosis induced by pro- and anti-inflammatory stimuli. Cell. Signal. 2010, 22:645-659.
222. Montopoli M., Ragazzi E., Froldi G., Caparrotta L. Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells. Cell Prolif. 2009, 42:195-206.
223. Moon Y.J., Wang L., DiCenzo R., Morris M.E. Quercetin pharmacokinetics in humans. Biopharm. Drug Dispos. 2008, 29:205-217.
224. Morin C., Zini R., Albengres E., Bertelli A.A., Bertelli A., Tillement J.P. Evidence for resveratrol-induced preservation of brain mitochondria functions after hypoxia-reoxygenation. Drugs Exp. Clin. Res. 2003, 29:227-233.
225. Mouria M., Gukovskaya A.S., Jung Y., Buechler P., Hines O.J., Reber H.A., Pandol S.J. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int. J. Cancer 2002, 98:761-769.
226. Mueller M., Beck V., Jungbauer A. PPARalpha activation by culinary herbs and spices. Planta Med. 2011, 77:497-504.
227. Muir C.S., Waterhouse J.A.H., Mack T.M., Powell J. Cancer incidence in five continents. IARC Scientific Publications No. 88 1987, V. International Agency for Research on Cancer, Lyon.
228. Muraoka K., Shimizu K., Sun X., Tani T., Izumi R., Miwa K., Yamamoto K. Flavonoids exert diverse inhibitory effects on the activation of NF-kappaB. Transplant. Proc. 2002, 34:1335-1340.
229. Murase T., Misawa K., Haramizu S., Hase T. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem. Pharmacol. 2009, 78:78-84.
230. Nagao T., Meguro S., Hase T., Otsuka K., Komikado M., Tokimitsu I., Yamamoto T., Yamamoto K. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity (Silver Spring) 2009, 17:310-317.
231. Nakae J., Kitamura T., Kitamura Y., Biggs W.H., Arden K.C., Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell 2003, 4:119-129.
232. Nam S., Smith D.M., Dou Q.P. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 2001, 276:13322-13330.
233. Narala V.R., Smith M.R., Adapala R.K., Ranga R., Panati K., Moore B.B., Leff T., Reddy V.D., Kondapi A.K., Reddy R.C. Curcumin is not a ligand for peroxisome proliferator-activated receptor-gamma. Gene Ther. Mol. Biol. 2009, 13:20-25.
234. Nguyen M.T., Favelyukis S., Nguyen A.K., Reichart D., Scott P.A., Jenn A., Liu-Bryan R., Glass C.K., Neels J.G., Olefsky J.M. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 2007, 282:35279-35292.
235. Nieman D.C., Williams A.S., Shanely R.A., Jin F., McAnulty S.R., Triplett N.T., Austin M.D., Henson D.A. Quercetin's influence on exercise performance and muscle mitochondrial biogenesis. Med. Sci. Sports Exerc. 2010, 42:338-345.
236. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., Otsu M., Hara K., Ueki K., Sugiura S., Yoshimura K., Kadowaki T., Nagai R. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 2009, 15:914-920.
237. Nishiyama T., Mae T., Kishida H., Tsukagawa M., Mimaki Y., Kuroda M., Sashida Y., Takahashi K., Kawada T., Nakagawa K., Kitahara M. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J. Agric. Food Chem. 2005, 53:959-963.
238. Nishizuka T., Fujita Y., Sato Y., Nakano A., Kakino A., Ohshima S., Kanda T., Yoshimoto R., Sawamura T. Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2011, 87:104-113.
239. O'Dea K. Westernisation, insulin resistance and diabetes in Australian aborigines. Med. J. Aust. 1991, 155:258-264.
240. Odegaard A.O., Koh W.P., Butler L.M., Duval S., Gross M.D., Yu M.C., Yuan J.M., Pereira M.A. Dietary patterns and incident type 2 diabetes in chinese men and women: the Singapore Chinese Health Study. Diabetes Care 2011, 34:880-885.
241. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., Li P., Lu W.J., Watkins S.M., Olefsky J.M. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.
242. Ohara K., Uchida A., Nagasaka R., Ushio H., Ohshima T. The effects of hydroxycinnamic acid derivatives on adiponectin secretion. Phytomedicine 2009, 16:130-137.
243. Ohmura K., Ishimori N., Ohmura Y., Tokuhara S., Nozawa A., Horii S., Andoh Y., Fujii S., Iwabuchi K., Onoe K., Tsutsui H. Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler. Thromb. Vasc. Biol. 2010, 30:193-199.
244. Ojewole J.A. Analgesic, antiinflammatory and hypoglycaemic effects of ethanol extract of Zingiber officinale (Roscoe) rhizomes (Zingiberaceae) in mice and rats. Phytother. Res. 2006, 20:764-772.
245. Okura A., Arakawa H., Oka H., Yoshinari T., Monden Y. Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells. Biochem. Biophys. Res. Commun. 1988, 157:183-189.
246. Olholm J., Paulsen S.K., Cullberg K.B., Richelsen B., Pedersen S.B. Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants. Int. J. Obes. (Lond) 2010, 34:1546-1553.
247. Osaka T., Kobayashi A., Namba Y., Ezaki O., Inoue S., Kimura S., Lee T.H. Temperature- and capsaicin-sensitive nerve fibers in brown adipose tissue attenuate thermogenesis in the rat. Pflugers Arch. 1998, 437:36-42.
248. Ottaviani J.I., Momma T.Y., Heiss C., Kwik-Uribe C., Schroeter H., Keen C.L. The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo. Free Radic. Biol. Med. 2011, 50:237-244.
249. Oyama J., Maeda T., Kouzuma K., Ochiai R., Tokimitsu I., Higuchi Y., Sugano M., Makino N. Green tea catechins improve human forearm endothelial dysfunction and have antiatherosclerotic effects in smokers. Circ. J. 2010, 74:578-588.
250. Pacholec M., Bleasdale J.E., Chrunyk B., Cunningham D., Flynn D., Garofalo R.S., Griffith D., Griffor M., Loulakis P., Pabst B., Qiu X., Stockman B., Thanabal V., Varghese A., Ward J., Withka J., Ahn K. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J. Biol. Chem. 2010, 285:8340-8351.
251. Pal D., Dasgupta S., Kundu R., Maitra S., Das G., Mukhopadhyay S., Ray S., Majumdar S.S., Bhattacharya S. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med. 2012, 10.1038/nm.2851.
252. Panayiotidis M.I., Rancourt R.C., Pappa A., White C.W. Effect of cell cycle growth arrest on global DNA methylation status in human lung epithelial-like (A549) cells. In Vivo 2006, 20:861-865.
253. Panunti B., Fonseca V. Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients. Vascul. Pharmacol. 2006, 45:29-35.
254. Pari L., Murugan P. Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Ren. Fail. 2007, 29:881-889.
255. Park K.K., Chun K.S., Lee J.M., Lee S.S., Surh Y.J. Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett. 1998, 129:139-144.
256. Park J.Y., Kawada T., Han I.S., Kim B.S., Goto T., Takahashi N., Fushiki T., Kurata T., Yu R. Capsaicin inhibits the production of tumor necrosis factor alpha by LPS-stimulated murine macrophages, RAW 264.7: a PPARgamma ligand-like action as a novel mechanism. FEBS Lett. 2004, 572:266-270.
257. Park H.J., Shin D.H., Chung W.J., Leem K., Yoon S.H., Hong M.S., Chung J.H., Bae J.H., Hwang J.S. Epigallocatechin gallate reduces hypoxia-induced apoptosis in human hepatoma cells. Life Sci. 2006, 78:2826-2832.
258. Park S.Y., Jeong K.J., Lee J., Yoon D.S., Choi W.S., Kim Y.K., Han J.W., Kim Y.M., Kim B.K., Lee H.Y. Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol. Cancer Lett. 2007, 258:63-69.
259. Park H.J., Yang J.Y., Ambati S., Della-Fera M.A., Hausman D.B., Rayalam S., Baile C.A. Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes. J. Med. Food 2008, 11:773-783.
260. Park S.S., Bae I., Lee Y.J. Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1alpha/2alpha is mediated through chelation of iron. J. Cell. Biochem. 2008, 103:1989-1998.
261. Park H.J., Della-Fera M.A., Hausman D.B., Rayalam S., Ambati S., Baile C.A. Genistein inhibits differentiation of primary human adipocytes. J. Nutr. Biochem. 2009, 20:140-148.
262. Pasarica M., Sereda O.R., Redman L.M., Albarado D.C., Hymel D.T., Roan L.E., Rood J.C., Burk D.H., Smith S.R. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 2009, 58:718-725.
263. Pedersen S.B., Olholm J., Paulsen S.K., Bennetzen M.F., Richelsen B. Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women. Int. J. Obes. (Lond) 2008, 32:1250-1255.
264. Pervaiz S. Resveratrol: from grapevines to mammalian biology. FASEB J. 2003, 17:1975-1985.
265. Pfeiffer E., Hoehle S.I., Walch S.G., Riess A., Solyom A.M., Metzler M. Curcuminoids form reactive glucuronides in vitro. J. Agric. Food Chem. 2007, 55:538-544.
266. Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., Machado D.O., Leid M., McBurney M.W., Guarente L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004, 429:771-776.
267. Prabhakar N.R., Shenoy B.C., Simonson M.S., Cherniack N.S. Cell selective induction and transcriptional activation of immediate early genes by hypoxia. Brain Res. 1995, 697:266-270.
268. Pungcharoenkul K., Thongnopnua P. Effect of different curcuminoid supplement dosages on total in vivo antioxidant capacity and cholesterol levels of healthy human subjects. Phytother. Res. 2011, 25:1721-1726.
269. Qureshi A.A., Tan X., Reis J.C., Badr M.Z., Papasian C.J., Morrison D.C., Qureshi N. Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models. Lipids Health Dis. 2011, 10:177.
270. Ramirez-Sanchez I., Maya L., Ceballos G., Villarreal F. (-)-Epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways. Hypertension 2010, 55:1398-1405.
271. Ramudu S.K., Korivi M., Kesireddy N., Lee L.C., Cheng I.S., Kuo C.H., Kesireddy S.R. Nephro-protective effects of a ginger extract on cytosolic and mitochondrial enzymes against streptozotocin (STZ)-induced diabetic complications in rats. Chin. J. Physiol. 2011, 54:79-86.
272. Rausch M.E., Weisberg S., Vardhana P., Tortoriello D.V. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int. J. Obes. (Lond) 2008, 32:451-463.
273. Ravindran J., Prasad S., Aggarwal B.B. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?. AAPS J. 2009, 11:495-510.
274. Rayalam S., Della-Fera M.A., Yang J.Y., Park H.J., Ambati S., Baile C.A. Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. J. Nutr. 2007, 137:2668-2673.
275. Rayalam S., Yang J.Y., Ambati S., Della-Fera M.A., Baile C.A. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother. Res. 2008, 22:1367-1371.
276. Regazzetti C., Peraldi P., Gremeaux T., Najem-Lendom R., Ben Sahra I., Cormont M., Bost F., Marchand-Brustel Y., Tanti J.F., Giorgetti-Peraldi S. Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes 2009, 58:95-103.
277. Reinbach H.C., Smeets A., Martinussen T., Moller P., Westerterp-Plantenga M.S. Effects of capsaicin, green tea and CH-19 sweet pepper on appetite and energy intake in humans in negative and positive energy balance. Clin. Nutr. 2009, 28:260-265.
278. Relic B., Zeddou M., Desoroux A., Beguin Y., de Seny D., Malaise M.G. Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts. Lab. Invest. 2009, 89:811-822.
279. Rios D.R., Rodrigues E.T., Cardoso A.P., Montes M.B., Franceschini S.A., Toloi M.R. Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women. Nutrition 2008, 24:1153-1158.
280. Rivera L., Moron R., Sanchez M., Zarzuelo A., Galisteo M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 2008, 16:2081-2087.
281. Rivera L., Moron R., Zarzuelo A., Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem. Pharmacol. 2009, 77:1053-1063.
282. Roberts A.T., Martin C.K., Liu Z., Amen R.J., Woltering E.A., Rood J.C., Caruso M.K., Yu Y., Xie H., Greenway F.L. The safety and efficacy of a dietary herbal supplement and gallic acid for weight loss. J. Med. Food 2007, 10:184-188.
283. Rocha V.Z., Folco E.J., Sukhova G., Shimizu K., Gotsman I., Vernon A.H., Libby P. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ. Res. 2008, 103:467-476.
284. Roghani M., Baluchnejadmojarad T. Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms. Vascul. Pharmacol. 2009, 51:84-89.
285. Roghani M., Baluchnejadmojarad T. Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats. Pathophysiology 2010, 17:55-59.
286. Saely C.H., Geiger K., Drexel H. Brown versus white adipose tissue: a mini-review. Gerontology 2010, 58:15-23.
287. Sakurai N., Mochizuki K., Kameji H., Shimada M., Goda T. (-)-Epigallocatechin gallate enhances the expression of genes related to insulin sensitivity and adipocyte differentiation in 3T3-L1 adipocytes at an early stage of differentiation. Nutrition 2009, 25:1047-1056.
288. Salih D.A., Brunet A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr. Opin. Cell Biol. 2008, 20:126-136.
289. Salminen A., Hyttinen J.M., Kaarniranta K. AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan. J. Mol. Med. (Berl) 2011, 89:667-676.
290. Sasaki H., Sunagawa Y., Takahashi K., Imaizumi A., Fukuda H., Hashimoto T., Wada H., Katanasaka Y., Kakeya H., Fujita M., Hasegawa K., Morimoto T. Innovative preparation of curcumin for improved oral bioavailability. Biol. Pharm. Bull. 2011, 34:660-665.
291. Schulz L.O., Bennett P.H., Ravussin E., Kidd J.R., Kidd K.K., Esparza J., Valencia M.E. Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S. Diabetes Care 2006, 29:1866-1871.
292. Sekiya K., Ohtani A., Kusano S. Enhancement of insulin sensitivity in adipocytes by ginger. Biofactors 2004, 22:153-156.
293. Senn J.J. Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J. Biol. Chem. 2006, 281:26865-26875.
294. Senocak F.S., Si Y., Moya C., Russell W.K., Russell D.H., Lee K., Jayaraman A. Effect of uncoupling protein-1 expression on 3T3-L1 adipocyte gene expression. FEBS Lett. 2007, 581:5865-5871.
295. Seo K.I., Choi M.S., Jung U.J., Kim H.J., Yeo J., Jeon S.M., Lee M.K. Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol. Nutr. Food Res. 2008, 52:995-1004.
296. Severson R.K., Nomura A.M., Grove J.S., Stemmermann G.N. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res. 1989, 49:1857-1860.
297. Shan T.Z., Ren Y., Wu T., Liu C.X., Wang Y.Z. Regulatory role of Sirt1 on the gene expression of fatty acid-binding protein 3 in cultured porcine adipocytes. J. Cell. Biochem. 2009, 107:984-991.
298. Shay N.F., Banz W.J. Regulation of gene transcription by botanicals: novel regulatory mechanisms. Annu. Rev. Nutr. 2005, 25:297-315.
299. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 116:3015-3025.
300. Shishodia S., Sethi G., Aggarwal B.B. Curcumin: getting back to the roots. Ann. N. Y. Acad. Sci. 2005, 1056:206-217.
301. Si H., Fu Z., Babu P.V., Zhen W., Leroith T., Meaney M.P., Voelker K.A., Jia Z., Grange R.W., Liu D. Dietary epicatechin promotes survival of obese diabetic mice and Drosophila melanogaster. J. Nutr. 2011, 141:1095-1100.
302. Simopoulos A.P. The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease. Asia Pac. J. Clin. Nutr. 2008, 17(Suppl. 1):131-134.
303. Singh R., Ahmed S., Islam N., Goldberg V.M., Haqqi T.M. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum. 2002, 46:2079-2086.
304. Smirin P., Taler D., Abitbol G., Brutman-Barazani T., Kerem Z., Sampson S.R., Rosenzweig T. Sarcopoterium spinosum extract as an antidiabetic agent: in vitro and in vivo study. J. Ethnopharmacol. 2010, 129:10-17.
305. Smith A.J., Kavuru P., Wojtas L., Zaworotko M.J., Shytle R.D. Cocrystals of quercetin with improved solubility and oral bioavailability. Mol. Pharm. 2011, 8:1867-1876.
306. Solinas G., Karin M. JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction. FASEB J. 2010, 24:2596-2611.
307. Solinas G., Vilcu C., Neels J.G., Bandyopadhyay G.K., Luo J.L., Naugler W., Grivennikov S., Wynshaw-Boris A., Scadeng M., Olefsky J.M., Karin M. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 2007, 6:386-397.
308. Somparn P., Phisalaphong C., Nakornchai S., Unchern S., Morales N.P. Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol. Pharm. Bull. 2007, 30:74-78.
309. Sozio M.S., Lu C., Zeng Y., Liangpunsakul S., Crabb D.W. Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301:G739-G747.
310. Steffen Y., Schewe T., Sies H. (-)-Epicatechin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase. Biochem. Biophys. Res. Commun. 2007, 359:828-833.
311. Stewart L.K., Soileau J.L., Ribnicky D., Wang Z.Q., Raskin I., Poulev A., Majewski M., Cefalu W.T., Gettys T.W. Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet. Metabolism 2008, 57:S39-S46.
312. Stünkel W., Campbell R.M. Sirtuin 1 (SIRT1): the misunderstood HDAC. J. Biomol. Screen. 2011, 16:1153-1169.
313. Su H.C., Hung L.M., Chen J.K. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E1339-E1346.
314. Subauste A.R., Burant C.F. Role of FoxO1 in FFA-induced oxidative stress in adipocytes. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E159-E164.
315. Surh Y.J. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem. Toxicol. 2002, 40:1091-1097.
316. Surh Y.J., Park K.K., Chun K.S., Lee L.J., Lee E., Lee S.S. Anti-tumor-promoting activities of selected pungent phenolic substances present in ginger. J. Environ. Pathol. Toxicol. Oncol. 1999, 18:131-139.
317. Suzuki J., Ogawa M., Futamatsu H., Kosuge H., Sagesaka Y.M., Isobe M. Tea catechins improve left ventricular dysfunction, suppress myocardial inflammation and fibrosis, and alter cytokine expression in rat autoimmune myocarditis. Eur. J. Heart Fail. 2007, 9:152-159.
318. Szkudelska K., Nogowski L., Szkudelski T. Genistein affects lipogenesis and lipolysis in isolated rat adipocytes. J. Steroid Biochem. Mol. Biol. 2000, 75:265-271.
319. Szkudelska K., Nogowski L., Szkudelski T. Genistein, a plant-derived isoflavone, counteracts the antilipolytic action of insulin in isolated rat adipocytes. J. Steroid Biochem. Mol. Biol. 2008, 109:108-114.
320. Szkudelska K., Nogowski L., Szkudelski T. Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes. J. Steroid Biochem. Mol. Biol. 2009, 113:17-24.
321. Szkudelska K., Nogowski L., Szkudelski T. Resveratrol and genistein as adenosine triphosphate-depleting agents in fat cells. Metabolism 2011, 60:720-729.
322. Tewksbury J.J., Nabhan G.P. Seed dispersal. Directed deterrence by capsaicin in chilies. Nature 2001, 412:403-404.
323. Tewksbury J.J., Reagan K.M., Machnicki N.J., Carlo T.A., Haak D.C., Penaloza A.L., Levey D.J. Evolutionary ecology of pungency in wild chilies. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:11808-11811.
324. Thielecke F., Rahn G., Bohnke J., Adams F., Birkenfeld A.L., Jordan J., Boschmann M. Epigallocatechin-3-gallate and postprandial fat oxidation in overweight/obese male volunteers: a pilot study. Eur. J. Clin. Nutr. 2010, 64:704-713.
325. Thomas R., Kim M.H. Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells. Biochem. Biophys. Res. Commun. 2005, 334:543-548.
326. Thompson D.B., de Gregorio M., Sommercorn J. Insulin regulation of multiple ribonucleic acid species in human skeletal muscle in insulin-sensitive and insulin-resistant subjects. J. Clin. Endocrinol. Metab. 1996, 81:519-523.
327. Timmers S., Konings E., Bilet L., Houtkooper R.H., van de W.T., Goossens G.H., Hoeks J., van der K.S., Ryu D., Kersten S., Moonen-Kornips E., Hesselink M.K., Kunz I., Schrauwen-Hinderling V.B., Blaak E.E., Auwerx J., Schrauwen P. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011, 14:612-622.
328. Tsai S.H., Lin-Shiau S.Y., Lin J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol. 1999, 126:673-680.
329. Tuntiwechapikul W., Taka T., Songsomboon C., Kaewtunjai N., Imsumran A., Makonkawkeyoon L., Pompimon W., Lee T.R. Ginger extract inhibits human telomerase reverse transcriptase and c-Myc expression in A549 lung cancer cells. J. Med. Food 2010, 13:1347-1354.
330. Ueki S., Miyoshi M., Shido O., Hasegawa J., Watanabe T. Systemic administration of [6]-gingerol, a pungent constituent of ginger, induces hypothermia in rats via an inhibitory effect on metabolic rate. Eur. J. Pharmacol. 2008, 584:87-92.
331. Vareed S.K., Kakarala M., Ruffin M.T., Crowell J.A., Normolle D.P., Djuric Z., Brenner D.E. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1411-1417.
332. Varga T., Czimmerer Z., Nagy L. PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim. Biophys. Acta 2011, 1812:1007-1022.
333. Venables M.C., Hulston C.J., Cox H.R., Jeukendrup A.E. Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am. J. Clin. Nutr. 2008, 87:778-784.
334. Vigilanza P., Aquilano K., Baldelli S., Rotilio G., Ciriolo M.R. Modulation of intracellular glutathione affects adipogenesis in 3T3-L1 cells. J. Cell. Physiol. 2011, 226:2016-2024.
335. Villa P., Costantini B., Suriano R., Perri C., Macri F., Ricciardi L., Panunzi S., Lanzone A. The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status. J. Clin. Endocrinol. Metab. 2009, 94:552-558.
336. Virtanen K.A., Lonnroth P., Parkkola R., Peltoniemi P., Asola M., Viljanen T., Tolvanen T., Knuuti J., Ronnemaa T., Huupponen R., Nuutila P. Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J. Clin. Endocrinol. Metab. 2002, 87:3902-3910.
337. Vogt P.K. Jun, the oncoprotein. Oncogene 2001, 20:2365-2377.
338. Walle T., Otake Y., Walle U.K., Wilson F.A. Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption. J. Nutr. 2000, 130:2658-2661.
339. Wang B., Li H., Yan H., Xiao J.G. Genistein inhibited hypoxia-inducible factor-1alpha expression induced by hypoxia and cobalt chloride in human retinal pigment epithelium cells. Methods Find. Exp. Clin. Pharmacol. 2005, 27:179-184.
340. Wang B., Wood I.S., Trayhurn P. Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch. 2007, 455:479-492.
341. Wang B., Wood I.S., Trayhurn P. Hypoxia induces leptin gene expression and secretion in human preadipocytes: differential effects of hypoxia on adipokine expression by preadipocytes. J. Endocrinol. 2008, 198:127-134.
342. Wang H., Wen Y., Du Y., Yan X., Guo H., Rycroft J.A., Boon N., Kovacs E.M., Mela D.J. Effects of catechin enriched green tea on body composition. Obesity (Silver Spring) 2010, 18:773-779.
343. Wang A., Liu M., Liu X., Dong L.Q., Glickman R.D., Slaga T.J., Zhou Z., Liu F. Up-regulation of adiponectin by resveratrol: the essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-L. J. Biol. Chem. 2011, 286:60-66.
344. Wein S., Behm N., Petersen R.K., Kristiansen K., Wolffram S. Quercetin enhances adiponectin secretion by a PPAR-gamma independent mechanism. Eur. J. Pharm. Sci. 2010, 41:16-22.
345. Weisberg S.P., Leibel R., Tortoriello D.V. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 2008, 149:3549-3558.
346. Weldin J., Jack R., Dugaw K., Kapur R.P. Quercetin, an over-the-counter supplement, causes neuroblastoma-like elevation of plasma homovanillic acid. Pediatr. Dev. Pathol. 2003, 6:547-551.
347. Woo H.M., Kang J.H., Kawada T., Yoo H., Sung M.K., Yu R. Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sci. 2007, 80:926-931.
348. Wood I.S., Stezhka T., Trayhurn P. Modulation of adipokine production, glucose uptake and lactate release in human adipocytes by small changes in oxygen tension. Pflugers Arch. 2011, 462:469-477.
349. Wu H., Ghosh S., Perrard X.D., Feng L., Garcia G.E., Perrard J.L., Sweeney J.F., Peterson L.E., Chan L., Smith C.W., Ballantyne C.M. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007, 115:1029-1038.
350. Wu H., Liang X., Fang Y., Qin X., Zhang Y., Liu J. Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells. Biomed. Pharmacother. 2008, 62:613-621.
351. Yamakuchi M., Bao C., Ferlito M., Lowenstein C.J. Epigallocatechin gallate inhibits endothelial exocytosis. Biol. Chem. 2008, 389:935-941.
352. Yamamoto Y., Gaynor R.B. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 2001, 107:135-142.
353. Yanez M., Galan L., Matias-Guiu J., Vela A., Guerrero A., Garcia A.G. CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: protection by resveratrol but not riluzole. Brain Res. 2011, 1423:77-86.
354. Yang J.Y., Della-Fera M.A., Rayalam S., Ambati S., Hartzell D.L., Park H.J., Baile C.A. Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci. 2008, 82:1032-1039.
355. Yang H.Y., Yang S.C., Chao J.C., Chen J.R. Beneficial effects of catechin-rich green tea and inulin on the body composition of overweight adults. Br. J. Nutr. 2012, 107:749-754.
356. Ye J., Gao Z., Yin J., He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1118-E1128.
357. Yon J.M., Baek I.J., Lee B.J., Yun Y.W., Nam S.Y. Emodin and [6]-gingerol lessen hypoxia-induced embryotoxicities in cultured mouse whole embryos via upregulation of hypoxia-inducible factor 1alpha and intracellular superoxide dismutases. Reprod. Toxicol. 2011, 31:513-518.
358. Yoneshiro T., Aita S., Kawai Y., Iwanaga T., Saito M. Nonpungent capsaicin analogs (capsinoids) increase energy expenditure through the activation of brown adipose tissue in humans. Am. J. Clin. Nutr. 2012, 95:845-850.
359. Yoon J.S., Lee H.J., Choi S.H., Chang E.J., Lee S.Y., Lee E.J. Quercetin inhibits IL-1beta-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from graves' orbitopathy. PLoS One 2011, 6:e26261.
360. Yoshioka M., Imanaga M., Ueyama H., Yamane M., Kubo Y., Boivin A., St Amand J., Tanaka H., Kiyonaga A. Maximum tolerable dose of red pepper decreases fat intake independently of spicy sensation in the mouth. Br. J. Nutr. 2004, 91:991-995.
361. Yu H.N., Ma X.L., Yang J.G., Shi C.C., Shen S.R., He G.Q. Comparison of effects of epigallocatechin-3-gallate on hypoxia injury to human umbilical vein, RF/6A, and ECV304 cells induced by Na(2)S(2)O(4). Endothelium 2007, 14:227-231.
362. Yu Y., Zick S., Li X., Zou P., Wright B., Sun D. Examination of the pharmacokinetics of active ingredients of ginger in humans. AAPS J. 2011, 13:417-426.
363. Yuan B., Zhen H., Jin Y., Xu L., Jiang X., Sun S., Li C., Xu H. Absorption and plasma disposition of genistin differ from those of genistein in healthy women. J. Agric. Food Chem. 2012, 60:1428-1436.
364. Zeyda M., Stulnig T.M. Adipose tissue macrophages. Immunol. Lett. 2007, 112:61-67.
365. Zhang J. Resveratrol inhibits insulin responses in a SirT1-independent pathway. Biochem. J. 2006, 397:519-527.
366. Zhang Q., Tang X., Lu Q.Y., Zhang Z.F., Brown J., Le A.D. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol. Cancer Ther. 2005, 4:1465-1474.
367. Zhang Q., Tang X., Lu Q., Zhang Z., Rao J., Le A.D. Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol. Cancer Ther. 2006, 5:1227-1238.
368. Zhang L.L., Yan L.D., Ma L.Q., Luo Z.D., Cao T.B., Zhong J., Yan Z.C., Wang L.J., Zhao Z.G., Zhu S.J., Schrader M., Thilo F., Zhu Z.M., Tepel M. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ. Res. 2007, 100:1063-1070.
369. Zhao J., Sun X.B., Ye F., Tian W.X. Suppression of fatty acid synthase, differentiation and lipid accumulation in adipocytes by curcumin. Mol. Cell. Biochem. 2011, 351:19-28.
370. Zheng J., Ramirez V.D. Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br. J. Pharmacol. 2000, 130:1115-1123.
371. Zhou Y.D., Kim Y.P., Li X.C., Baerson S.R., Agarwal A.K., Hodges T.W., Ferreira D., Nagle D.G. Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts. J. Nat. Prod. 2004, 67:2063-2069.
372. Zhu J., Yong W., Wu X., Yu Y., Lv J., Liu C., Mao X., Zhu Y., Xu K., Han X., Liu C. Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes. Biochem. Biophys. Res. Commun. 2008, 369:471-477.
373. Zhu X., Liu Q., Wang M., Liang M., Yang X., Xu X., Zou H., Qiu J. Activation of Sirt1 by resveratrol inhibits TNF-alpha induced inflammation in fibroblasts. PLoS One 2011, 6:e27081.
374. Zick S.M., Djuric Z., Ruffin M.T., Litzinger A.J., Normolle D.P., Alrawi S., Feng M.R., Brenner D.E. Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1930-1936.
375. Zick S.M., Turgeon D.K., Vareed S.K., Ruffin M.T., Litzinger A.J., Wright B.D., Alrawi S., Normolle D.P., Djuric Z., Brenner D.E. Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer. Cancer Prev. Res. (Phila.) 2011, 4:1929-1937.
376. Zimmet P., Dowse G., Finch C., Serjeantson S., King H. The epidemiology and natural history of NIDDM-lessons from the South Pacific. Diabetes Metab. Rev. 1990, 6:91-124.
377. Zini R., Morin C., Bertelli A., Bertelli A.A., Tillement J.P. Effects of resveratrol on the rat brain respiratory chain. Drugs Exp. Clin. Res. 1999, 25:87-97.
378. Zoechling A., Liebner F., Jungbauer A. Red wine: a source of potent ligands for peroxisome proliferator-activated receptor gamma. Food Funct. 2011, 2:28-38.